S433 100 mg (Carbamazepine extended-release 100 mg)
Pill imprint S433 100 mg has been identified as Carbamazepine extended-release 100 mg.
Carbamazepine is used in the treatment of trigeminal neuralgia; bipolar disorder; epilepsy; schizoaffective disorder; cluster-tic syndrome (and more), and belongs to the drug class dibenzazepine anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Carbamazepine 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for S433 100 mg
- 100 mg
- Prescription only
- Drug Class:
- Dibenzazepine anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Prasco Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- citric acid monohydrate
sodium lauryl sulfate
FD&C Blue No. 2
ferric oxide yellow
More about carbamazepine
- Carbamazepine chewable tablets
- Carbamazepine suspension
- Carbamazepine sustained-release capsules
- Carbamazepine sustained-release tablets
- Carbamazepine (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.